Fulcrum Therapeutics, Inc. (FULC)
9.74
+0.19
(+1.99%)
USD |
NASDAQ |
Feb 06, 16:00
9.55
-0.19
(-1.95%)
After-Hours: 20:00
Fulcrum Therapeutics SG&A Expense (TTM) : 29.10M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Agios Pharmaceuticals, Inc. | 180.37M |
| CorMedix, Inc. | 75.56M |
| ACADIA Pharmaceuticals, Inc. | 523.36M |
| Alnylam Pharmaceuticals, Inc. | 1.181B |
| Savara, Inc. | 37.38M |